B-063

Brivaracetam-D₃ solution

100 μg/mL in methanol, certified reference material, ampule of 1 mL, Cerilliant^®

• Formule empirique (notation de Hill) : C₁₁H₁₇D₃N₂O₂
• Poids moléculaire : 215.31
• UNSPSC Code: 41116107
• NACRES: NA.24
• MDL number: MFCD00055143

Propriétés

• Quality Segment: 300
• grade: certified reference material
• form: liquid
• feature: Snap-N-Spike^®/Snap-N-Shoot^®
• packaging: ampule of 1 mL
• manufacturer/tradename: Cerilliant^®
• concentration: 100 μg/mL in methanol
• technique(s): gas chromatography (GC): suitable, liquid chromatography (LC): suitable
• format: single component solution
• storage temp.: −20°C
• SMILES string: Clc1ccc(cc1)C(CN)CC(=O)O
• InChI: 1S/C10H12ClNO2/c11-9-3-1-7(2-4-9)8(6-12)5-10(13)14/h1-4,8H,5-6,12H2,(H,13,14)
• InChI key: KPYSYYIEGFHWSV-UHFFFAOYSA-N

Description

General description

An internal standard suitable for GC/MS or LC/MS applications in brivaracetam testing from clinical toxicology and forensic analysis to urine drug testing and isotope dilution methods. Brivaracetam is an antiepileptic drug for the treatment of partial-onset seizures. The drug is marketed under the trade name Briviact^®.

Legal Information

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany

Snap-N-Shoot is a registered trademark of Cerilliant Corporation

Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

Supply conditions do not apply to the regions and states of Brazil: North, Northeast, Mato Grosso do Sul, Mato Grosso, and Rio Grande do Sul.

Informations sur la sécurité

• target_organs: Eyes
• pictograms: GHS02,GHS06,GHS08
• signalword: Danger
• hcodes: H225,H301 + H311 + H331,H370
• pcodes: P210 - P280 - P301 + P310 + P330 - P302 + P352 + P312 - P304 + P340 + P311
• Hazard Classifications: Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1
• Classe de stockage: 3 - Flammable liquids
• wgk: WGK 2
• flash_point_f: 49.5 °F - closed cup
• flash_point_c: 9.7 °C - closed cup